Dr. Wu Mingjie’s Authentic Overseas Medical Case: JAK2 Gene Mutation with Persistently Elevated Platelets Over 900×10⁹/L; Two-Year Regulation with Classical Prescriptions and Tuina Therapy
Many patients suffering from myeloproliferative hematological disorders share the same predicament:
After being diagnosed with genetic mutations and skyrocketing platelet counts, they mostly rely on long-term Western medicine to suppress lab indicators. While such treatment stabilizes conditions temporarily, it fails to address root issues including severe physical fatigue, qi and blood deficiency, and poor mental wellbeing. Once medication is discontinued, indicators rebound sharply, and prolonged drug intake imposes a heavy burden on the liver and kidneys.
Today we present an extremely valuable real overseas medical case from Dr. Wu Mingjie.
The patient has retained full laboratory test records spanning 32 years from 1994 to 2026, featuring complete and verifiable datasets. Systematic pure Traditional Chinese Medicine (TCM) regulation was administered for two full consecutive years, with all improvements validated solely by lab test results without any exaggeration.
I. Full Disease Profile and Regulation Process
As early as 32 years ago, the patient presented chronically low red blood cell counts and insufficient qi and blood, accompanied by persistent exhaustion and shortness of breath. In the early stage, modified Buzhong Yiqi Decoction regulated blood deficiency and kept the condition relatively stable.
In 2021, the patient was formally diagnosed with essential thrombocythemia, and genetic testing confirmed a JAK2 gene mutation.
This is a chronic myeloproliferative disorder that is clinically difficult to eradicate completely, with the patient’s platelet count climbing year by year.
In August 2024, the platelet count peaked at 988 K/μL,
far exceeding the safe reference range of 150–450 K/μL, placing the patient at high risk of thrombosis.
Starting in October 2024, the patient underwent uninterrupted systematic TCM management under Dr. Wu Mingjie for exactly two years.
The regulation combined two modalities: external therapy and oral herbal prescriptions.
External Therapy: Weekly tuina massage on the Governor Vessel and Bladder Meridian to dredge general qi movement and unblock the ascending-descending pathways of the middle energizer (spleen and stomach).
Oral Classical Prescription: Modified Zhenwu Decoction from Treatise on Febrile Diseases as the foundational formula, supplemented with Smilax glabra, Ganoderma lucidum, Curcuma longa and Carapax Trionycis to reinforce healthy qi, warm yang, dissipate blood stasis and promote diuresis. Herbs were prepared into standardized concentrated powder, taken twice daily on a regular schedule.
II. Objective Improvements in Three Groups of Lab Indicators After Two Years of Regulation
All datasets are original scanned test results provided by the patient, unaltered and unfabricated.
1. Platelet Count (Core High-Risk Indicator)
Peak value before treatment: 988 K/μL
Latest recheck after two years: 858 K/μL
The figure declined steadily with no drastic fluctuations.
Subjective improvements reported by the patient included reduced dizziness, alleviated bodily heaviness, greater overall comfort, and markedly lowered thrombotic risk.
2. Red Blood Cells and Qi-Blood Status
The patient had suffered from chronically low red blood cell levels, qi-blood depletion, easy fatigue and sallow complexion for decades.
Following long-term root-strengthening herbal conditioning, red blood cell counts have stabilized within the normal range of 3.92~4.02 M/μL over the past year.
Symptoms such as shortness of breath, lassitude and pale sallow complexion were largely resolved, with significant replenishment of qi and blood.
3. Ferritin Level (Systemic Qi-Blood Reserve Marker)
2010–2014: 20~36 μg/L, indicating severe depletion of bodily qi and blood reserves
Post two-year regulation: sustained at 50~101 μg/L
This reading confirms the resolution of long-term constitutional deficiency, robust healthy qi and comprehensive physical improvement.
III. Dr. Wu Mingjie’s Core Therapeutic Approach
Most practitioners only focus on suppressing elevated lab values in disease management.
TCM, by contrast, targets the whole bodily internal environment.
Patients with JAK2 mutations and abnormally high platelets commonly present with:
deficient spleen and kidney yang, stagnated middle energizer, heavy internal dampness and static blood in the nutrient blood layer
dysfunctional communication between heart fire (unable to descend) and kidney water (unable to ascend)
disordered systemic qi circulation, which triggers persistent abnormal proliferation of bone marrow cells.
Dr. Wu’s therapeutic logic is straightforward:
Zhenwu Decoction warms the spleen and kidneys, drains dampness and replenishes yang energy;
Carapax Trionycis and Curcuma longa dissolve blood stasis and unblock meridians;
Ganoderma lucidum and Smilax glabra build up physical resistance for long-term root reinforcement;
complementary tuina therapy unlocks the ascending and descending circulation of qi.
The regimen does not forcibly suppress indicators, but rebalances the disrupted internal bodily environment.
In discussing chronic and intractable disease rehabilitation based on this case, Dr. Wu Mingjie emphasizes: easing patients’ psychological fear is pivotal to recovery. Mental mindset governs physical and functional conditions; only by grounding oneself in the present can the body accumulate self-healing capacity.
There exists an intrinsic law linking mind and body: excessive fear of cancer consumes healthy qi; persistent worry about disease progression or deterioration disrupts qi and blood harmony. Chronic anxiety over poverty or lingering illness only exacerbates all physical discomforts.
He also states objectively:
Genetic abnormalities can hardly be permanently “eradicated”.
Nevertheless, the greatest merit of this case lies in:
no additional Western medications or aggressive interventions adopted, steady reduction of pathological indicators via pure TCM therapy, comprehensive physical fitness enhancement and decreased risk of complications.
This embodies the true value of integrated Chinese and Western medicine.
Dr. Wu's dialectical view on red blood cell indicators
In this case, one issue is that in 1994, the Western standard for normal red blood cell counts was 3.6. When the patient was 28 years old, 32 years ago, their red blood cell count was 3.76, which was within the normal range. In 2026, because Western interest groups changed the normal standard to 4, the same patient, now 61 years old, with a red blood cell count of 9.92, would be considered sick according to current diagnostic standards. However, this patient's red blood cell count last year and this year has been around 3.9, which is actually better than 32 years ago at 3.76, and their overall health and physical condition are better now than before.
Interactive Closing
Are there any fellow patients diagnosed with essential thrombocythemia, JAK2 gene mutation or other myeloproliferative disorders?
Do you frequently suffer from fatigue, poor sleep, qi-blood deficiency and heavy bodily sensations while taking long-term Western medications?
Feel free to share your platelet counts, disease course and physical discomforts in the comments section.
Readers seeking Dr. Wu Mingjie’s complete syndrome differentiation framework for this modified Zhenwu Decoction regimen,
please bookmark this article and comment with the keyword Need, and we will compile and send the full materials to you collectively.
We keep sharing authentic TCM medical cases, scanned laboratory reports and practical application experience of classical herbal prescriptions on an ongoing basis.
Follow us to access more real-world chronic disease conditioning cases!
About the author
Liu Jiaqi, Chief Physician, Colorectal & Anal Surgery, Beihai People's Hospital; disciple of Dr. Wu Mingjie (Fengyang lineage); specialist in integrated Chinese-Western medicine; fourth-generation inheritor of TCM Grand Master Deng Tietao.
